Showing results (521-530 of 1,335) with videos related to
Sort By:
Pageof 134
Journal of Diabetes|July 11, 2019
Dietary preferences and diabetic risk in China: A large-scale nationwide Internet data-based studyZhiyun Zhao, Mian Li, Chao Li, et al.Journal of Diabetes|March 1, 2022
Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturiaEmre Durcan, Serbay Ozkan, Halil Ibrahim Saygi, et al.Journal of Diabetes|March 1, 2022
Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitorQian Ren, Siqian Gong, Xuyao Han, et al.Journal of Diabetes|October 10, 2019
Emerging trends and the clinical impact of food insecurity in patients with diabetesKristen L Flint, Georgia M Davis, Guillermo E UmpierrezJournal of Diabetes|April 13, 2023
The association between daytime napping and risk of type 2 diabetes is modulated by inflammation and adiposity: Evidence from 435 342 UK-Biobank participantsRui Zhou, Hao-Wen Chen, Yi-Ning Huang, et al.Journal of Diabetes|April 11, 2023
Association of alcohol consumption with all-cause mortality, new-onset stroke, and coronary heart disease in patients with abnormal glucose metabolism-Findings from a 10-year follow-up of the REACTION studyMengzhao Cui, Fei Li, Xiaokun Gang, et al.Journal of Diabetes|September 18, 2012
Effect of Diamel in patients with metabolic syndrome: a randomized double-blind placebo-controlled studyEduardo Cabrera-Rode, Neraldo Orlandi, Yaneysi Padrón, et al.Journal of Diabetes|May 5, 2023
Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non-glycemic factors to HbA1c in individuals with type 1 diabetesYongwen Zhou, Mao Zheng, Hongrong Deng, et al.Journal of Diabetes|August 25, 2020
Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetesYanyan Chen, Heng Zhang, Xiaopei Hou, et al.Journal of Diabetes|July 2, 2020
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trialHyunju Kim, Dan Wang, John Chalmers, et al.Pageof 134